-
David Graham Speaks at May 2005 Event About Need for Change at FDA
FDA was "the single greatest obstacle" as to Vioxx Withdrawal David Graham says the FDA, itself, was the "single greatest obstacle to doing anything effective" about getting the unsafe prescription drug Vioxx withdrawn from…
-
Natrecor Given Regularly to Outpatients is Focus of Current Safety Controversy
In May 2005 Scios Sent a Natrecor "Dear Doctor" Letter to Heart Doctors Natrecor is a prescription drug approved by the FDA as a therapy for hospitalized patients or those rushed to emergency rooms…
-
Viagra, Other ED Drugs Possibly Linked With Vision Loss and Blindness
FDA To Consider Warning Label Changes for Viagra, Cialis, and Levitra The FDA is investigating numerous reports of a possible serious side effect from the use of Viagra and other impotence, or erectile dysfunction…
-
Health Canada Announces Its Adverse Drug Reaction Database is Now Searchable by Public Online
FDA Should Follow Health Canada’s Lead and Permit Direct Access to MedWatch Adverse Reaction Reports Health Canada has announced it is now allowing direct access to the latest reported adverse reactions to prescription drugs…
-
FDA Drug-safety Oversight Efforts Must Improve to Avoid Another Vioxx Debacle
Dr. Garret FitzGerald’s Speech in May 2005 at Edinburgh, Scotland Dr. Garret FitzGerald, a highly regarded medical doctor at the University of Pennsylvania, told a conference in Edinburgh, Scotland that the problems surrounding the…
-
Crestor Side Effects: Reports to FDA MedWatch Analyzed by Tufts Doctors
Crestor-Rhabdomyolysis Link: New Study May Support Allegations by Public Citizen Group Rhabdomyolysis, proteinuria, nephropathy, and kidney or renal failure are serious side effects which apparently occur more often with the use of Crestor (rosuvastatin)…
